NTG CLARITY NETWORKS INC (NCI.CA) Fundamental Analysis & Valuation

TSX-V:NCI • CA62940V2030

Current stock price

1.06 CAD
-0.1 (-8.62%)
Last:

This NCI.CA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

6

1. NCI.CA Profitability Analysis

1.1 Basic Checks

  • In the past year NCI was profitable.
  • NCI had a negative operating cash flow in the past year.
  • NCI had positive earnings in 4 of the past 5 years.
  • In the past 5 years NCI always reported a positive cash flow from operatings.
NCI.CA Yearly Net Income VS EBIT VS OCF VS FCFNCI.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M 10M -10M

1.2 Ratios

  • NCI has a Return On Assets of 17.08%. This is amongst the best in the industry. NCI outperforms 91.04% of its industry peers.
  • NCI has a better Return On Equity (28.01%) than 92.54% of its industry peers.
  • NCI has a Return On Invested Capital of 23.79%. This is amongst the best in the industry. NCI outperforms 95.52% of its industry peers.
Industry RankSector Rank
ROA 17.08%
ROE 28.01%
ROIC 23.79%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
NCI.CA Yearly ROA, ROE, ROICNCI.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200 -200 400

1.3 Margins

  • NCI's Profit Margin of 9.85% is fine compared to the rest of the industry. NCI outperforms 79.10% of its industry peers.
  • NCI's Profit Margin has improved in the last couple of years.
  • NCI's Operating Margin of 13.86% is fine compared to the rest of the industry. NCI outperforms 76.12% of its industry peers.
  • NCI's Operating Margin has declined in the last couple of years.
  • NCI has a worse Gross Margin (35.76%) than 64.18% of its industry peers.
  • In the last couple of years the Gross Margin of NCI has grown nicely.
Industry RankSector Rank
OM 13.86%
PM (TTM) 9.85%
GM 35.76%
OM growth 3Y-3.27%
OM growth 5YN/A
PM growth 3Y14.92%
PM growth 5YN/A
GM growth 3Y-12.47%
GM growth 5Y7.3%
NCI.CA Yearly Profit, Operating, Gross MarginsNCI.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100

6

2. NCI.CA Health Analysis

2.1 Basic Checks

  • NCI has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
  • NCI has more shares outstanding than it did 1 year ago.
  • The number of shares outstanding for NCI has been increased compared to 5 years ago.
  • Compared to 1 year ago, NCI has an improved debt to assets ratio.
NCI.CA Yearly Shares OutstandingNCI.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2023 2024 50M 100M
NCI.CA Yearly Total Debt VS Total AssetsNCI.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2023 2024 5M 10M 15M 20M 25M

2.2 Solvency

  • NCI has an Altman-Z score of 4.84. This indicates that NCI is financially healthy and has little risk of bankruptcy at the moment.
  • NCI has a Altman-Z score of 4.84. This is in the better half of the industry: NCI outperforms 76.12% of its industry peers.
  • NCI has a Debt/Equity ratio of 0.19. This is a healthy value indicating a solid balance between debt and equity.
  • The Debt to Equity ratio of NCI (0.19) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.19
Debt/FCF N/A
Altman-Z 4.84
ROIC/WACC2.52
WACC9.44%
NCI.CA Yearly LT Debt VS Equity VS FCFNCI.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M 10M -10M

2.3 Liquidity

  • A Current Ratio of 3.13 indicates that NCI has no problem at all paying its short term obligations.
  • NCI's Current ratio of 3.13 is amongst the best of the industry. NCI outperforms 83.58% of its industry peers.
  • NCI has a Quick Ratio of 3.13. This indicates that NCI is financially healthy and has no problem in meeting its short term obligations.
  • NCI has a better Quick ratio (3.13) than 83.58% of its industry peers.
Industry RankSector Rank
Current Ratio 3.13
Quick Ratio 3.13
NCI.CA Yearly Current Assets VS Current LiabilitesNCI.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2023 2024 5M 10M 15M 20M

8

3. NCI.CA Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an nice 15.26% over the past year.
  • The Earnings Per Share has been growing by 68.04% on average over the past years. This is a very strong growth
  • NCI shows a strong growth in Revenue. In the last year, the Revenue has grown by 62.61%.
  • NCI shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 45.43% yearly.
EPS 1Y (TTM)15.26%
EPS 3Y68.04%
EPS 5YN/A
EPS Q2Q%-15.85%
Revenue 1Y (TTM)62.61%
Revenue growth 3Y67.72%
Revenue growth 5Y45.43%
Sales Q2Q%42.22%

3.2 Future

  • The Earnings Per Share is expected to grow by 7.62% on average over the next years.
  • The Revenue is expected to grow by 26.70% on average over the next years. This is a very strong growth
EPS Next Y-29.54%
EPS Next 2Y-2.61%
EPS Next 3Y7.62%
EPS Next 5YN/A
Revenue Next Year45.61%
Revenue Next 2Y31.42%
Revenue Next 3Y26.7%
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
  • The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
NCI.CA Yearly Revenue VS EstimatesNCI.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 20M 40M 60M 80M 100M
NCI.CA Yearly EPS VS EstimatesNCI.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 0.05 0.1 0.15 0.2

6

4. NCI.CA Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 7.57, the valuation of NCI can be described as very cheap.
  • 88.06% of the companies in the same industry are more expensive than NCI, based on the Price/Earnings ratio.
  • When comparing the Price/Earnings ratio of NCI to the average of the S&P500 Index (27.87), we can say NCI is valued rather cheaply.
  • With a Price/Forward Earnings ratio of 5.88, the valuation of NCI can be described as very cheap.
  • Based on the Price/Forward Earnings ratio, NCI is valued cheaply inside the industry as 85.07% of the companies are valued more expensively.
  • The average S&P500 Price/Forward Earnings ratio is at 38.51. NCI is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 7.57
Fwd PE 5.88
NCI.CA Price Earnings VS Forward Price EarningsNCI.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • NCI's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. NCI is cheaper than 86.57% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 4.12
NCI.CA Per share dataNCI.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5

4.3 Compensation for Growth

  • The decent profitability rating of NCI may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-2.61%
EPS Next 3Y7.62%

0

5. NCI.CA Dividend Analysis

5.1 Amount

  • NCI does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

NCI.CA Fundamentals: All Metrics, Ratios and Statistics

NTG CLARITY NETWORKS INC

TSX-V:NCI (4/17/2026, 7:00:00 PM)

1.06

-0.1 (-8.62%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)11-12
Earnings (Next)N/A
Inst Owners0.22%
Inst Owner ChangeN/A
Ins Owners24.37%
Ins Owner ChangeN/A
Market Cap50.76M
Revenue(TTM)76.65M
Net Income(TTM)7.55M
Analysts85.45
Price Target3.67 (246.23%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-59.73%
Min EPS beat(2)-85.29%
Max EPS beat(2)-34.18%
EPS beat(4)1
Avg EPS beat(4)-14.44%
Min EPS beat(4)-85.29%
Max EPS beat(4)94.17%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-2.48%
Min Revenue beat(2)-5.69%
Max Revenue beat(2)0.73%
Revenue beat(4)3
Avg Revenue beat(4)1.13%
Min Revenue beat(4)-5.69%
Max Revenue beat(4)8.23%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-9.24%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)-35%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-1.53%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.71%
Valuation
Industry RankSector Rank
PE 7.57
Fwd PE 5.88
P/S 0.66
P/FCF N/A
P/OCF N/A
P/B 1.88
P/tB 2.17
EV/EBITDA 4.12
EPS(TTM)0.14
EY13.21%
EPS(NY)0.18
Fwd EY17%
FCF(TTM)-0.13
FCFYN/A
OCF(TTM)-0.1
OCFYN/A
SpS1.6
BVpS0.56
TBVpS0.49
PEG (NY)N/A
PEG (5Y)N/A
Graham Number1.33182 (25.64%)
Profitability
Industry RankSector Rank
ROA 17.08%
ROE 28.01%
ROCE 33.04%
ROIC 23.79%
ROICexc 29.91%
ROICexgc 34.7%
OM 13.86%
PM (TTM) 9.85%
GM 35.76%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-3.27%
OM growth 5YN/A
PM growth 3Y14.92%
PM growth 5YN/A
GM growth 3Y-12.47%
GM growth 5Y7.3%
F-Score5
Asset Turnover1.73
Health
Industry RankSector Rank
Debt/Equity 0.19
Debt/FCF N/A
Debt/EBITDA 0.43
Cap/Depr 101.9%
Cap/Sales 1.94%
Interest Coverage 31.2
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.13
Quick Ratio 3.13
Altman-Z 4.84
F-Score5
WACC9.44%
ROIC/WACC2.52
Cap/Depr(3y)274.99%
Cap/Depr(5y)720.23%
Cap/Sales(3y)6.12%
Cap/Sales(5y)8.5%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)15.26%
EPS 3Y68.04%
EPS 5YN/A
EPS Q2Q%-15.85%
EPS Next Y-29.54%
EPS Next 2Y-2.61%
EPS Next 3Y7.62%
EPS Next 5YN/A
Revenue 1Y (TTM)62.61%
Revenue growth 3Y67.72%
Revenue growth 5Y45.43%
Sales Q2Q%42.22%
Revenue Next Year45.61%
Revenue Next 2Y31.42%
Revenue Next 3Y26.7%
Revenue Next 5YN/A
EBIT growth 1Y53.89%
EBIT growth 3Y62.24%
EBIT growth 5YN/A
EBIT Next Year19.12%
EBIT Next 3Y25.69%
EBIT Next 5YN/A
FCF growth 1Y-1129.52%
FCF growth 3Y85.08%
FCF growth 5YN/A
OCF growth 1Y-287.68%
OCF growth 3Y12.61%
OCF growth 5Y234.98%

NTG CLARITY NETWORKS INC / NCI.CA Fundamental Analysis FAQ

What is the fundamental rating for NCI stock?

ChartMill assigns a fundamental rating of 6 / 10 to NCI.CA.


What is the valuation status for NCI stock?

ChartMill assigns a valuation rating of 6 / 10 to NTG CLARITY NETWORKS INC (NCI.CA). This can be considered as Fairly Valued.


What is the profitability of NCI stock?

NTG CLARITY NETWORKS INC (NCI.CA) has a profitability rating of 6 / 10.


What is the valuation of NTG CLARITY NETWORKS INC based on its PE and PB ratios?

The Price/Earnings (PE) ratio for NTG CLARITY NETWORKS INC (NCI.CA) is 7.57 and the Price/Book (PB) ratio is 1.88.